PET With C-11-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma-论文-万方医学网

首页> > PET With C-11-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma

PET With C-11-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma

导出原文传递

翻译打印收藏纠错

第一作者： Beppu, Takaaki

作者： Beppu, Takaaki ^[1] ; Iwaya, Takeshi ^[2] ; Sato, Yuichi ^[3] ; Nomura, Jun-ichi ^[4] ; Terasaki, Kazunori ; Sasaki, Toshiaki ; Yamada, Noriyuki ; Fujiwara, Shunrou ; Sugai, Tamotsu ; Ogasawara, Kuniaki

作者单位： Dept Neurosurg,Iwate Med Univ ^[1] Dept Surg,Iwate Med Univ ^[2] Div High Energy Med Res,Iwate Med Univ ^[3] Dept Clin Pathol,Iwate Med Univ ^[4]

关键词 IDH-mutant lower-grade glioma C-11-methionine PET temozolomide adjuvant chemotherapy MGMT methylation status C-11-METHIONINE PET

发布时间 2022-09-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

PET With C-11-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma

相似文献

同项目论文

相关期刊

检索历史 清除

PET With C-11-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma

相似文献

同项目论文

相关期刊

检索历史清除